These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 22316121)

  • 1. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
    Kaushansky N; Eisenstein M; Boura-Halfon S; Hansen BE; Nielsen CH; Milo R; Zeilig G; Lassmann H; Altmann DM; Ben-Nun A
    J Biol Chem; 2015 Jun; 290(24):15260-78. PubMed ID: 25911099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
    Kaushansky N; Ben-Nun A
    Front Oncol; 2014; 4():280. PubMed ID: 25360418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma.
    Mangalam A; Luckey D; Basal E; Behrens M; Rodriguez M; David C
    J Immunol; 2008 Jun; 180(11):7747-56. PubMed ID: 18490779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
    Mangalam AK; Khare M; Krco C; Rodriguez M; David C
    Eur J Immunol; 2004 Jan; 34(1):280-90. PubMed ID: 14971054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.
    Lincoln MR; Ramagopalan SV; Chao MJ; Herrera BM; Deluca GC; Orton SM; Dyment DA; Sadovnick AD; Ebers GC
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7542-7. PubMed ID: 19380721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.
    Luckey D; Bastakoty D; Mangalam AK
    J Autoimmun; 2011 Sep; 37(2):122-8. PubMed ID: 21632210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.
    Mangalam AK; Luo N; Luckey D; Papke L; Hubbard A; Wussow A; Smart M; Giri S; Rodriguez M; David C
    J Immunol; 2014 Nov; 193(10):4859-70. PubMed ID: 25339670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
    Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
    Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
    Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
    Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
    Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
    Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution HLA class II sequencing of Swedish multiple sclerosis patients.
    Akel O; Zhao LP; Geraghty DE; Lind A
    Int J Immunogenet; 2022 Oct; 49(5):333-339. PubMed ID: 35959717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
    Kumar A; Melis P; Genna V; Cocco E; Marrosu MG; Pieroni E
    Mol Biosyst; 2014 Aug; 10(8):2043-54. PubMed ID: 24853027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.
    Quandt JA; Huh J; Baig M; Yao K; Ito N; Bryant M; Kawamura K; Pinilla C; McFarland HF; Martin R; Ito K
    J Immunol; 2012 Sep; 189(6):2897-908. PubMed ID: 22888134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
    Kort JJ; Kawamura K; Fugger L; Weissert R; Forsthuber TG
    J Neuroimmunol; 2006 Apr; 173(1-2):23-34. PubMed ID: 16386804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.